consideration and approval in accordance with the process required by the Private Investment in State Undertakings Act B.E.2556 (2013). Nevertheless, there would be a change in the aforementioned guidelines as
: Million Baht 2018 2017 Change Amount % Amount % Amount % Revenues from dental service 456.15 96.64 386.72 98.70 69.43 17.95 Other revenues 15.88 3.36 5.11 1.30 10.77 210.63 Total revenues from medical
Baht) Separate financial statements 2018 2017 % Change Sales and Service Income 1,940.22 1,979.16 (1.97) Cost of Sales and Services 1,572.51 1,525.25 3.10 Selling and Administrative Expenses 218.91
% decreased, the details of the change are as follows: 1.1 Current asset as of December 31, 2019 with amount of 196.16 million bath decreased by 6.62 million bath or 3.27% decreased due to the main reason of
Baht or cost and Gross P The Co represe is slight 2017 wa same pe Service The Com 30.51 m month e 75.60% and em Summa Assets Cash a Trade Prope Invest Lease Depos Total Ass Liabilities OD an Trade Long-t
year were as highlighted below ; (Unit : Million Baht) Q2/2017 Q2/2016 % Change Sales 521 501 4 Gross Profit Margin 24% 29% -5 Selling and Administrative Expenses 53 55 -4 Financial Cost 8 9 -11 Net
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 195/2560 November 8, 2017 Subject: Clarification of the Operating Result for the significant change Attention
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 195/2560 November 8, 2017 Subject: Clarification of the Operating Result for the significant change - Update
highlighted below; (Unit : Million Baht) Separate financial statements Q1/2019 Q1/2018 % Change Sales and Service Income 485 467 4 Cost of Sales and Services 388 384 1 Selling and Administrative Expenses 44 51
operating performance of the Company three-month for the Quarter 1/2019 ended 31 March 2019 are as follows: change Q1/2562 Q1/2561 increase (decrease) Sales 213.9 189.1 13.1% Other income 10.8 15.9 -32.2